SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Rimini Street, Inc. (RMNI) (CIK 0001635282) (RMNI) — Apr 9, 2015

Rimini Street, Inc. (RMNI) (CIK 0001635282)
Date: April 9, 2015 · CIK: 0001635282 · Accession: 0000000000-15-020510

AI Filing Summary & Sentiment

Date
April 9, 2015
Author
/s/ Erin E. Martin
Form
UPLOAD
Company
Rimini Street, Inc. (RMNI) (CIK 0001635282)

Letter

April 9, 2015 Via E -mail Antonio Bonchristiano Chief Executive Officer GP Investments Acquisition Corp. 150 E. 52nd Street, Suite 5003 New York, NY 10022

Re: GP Investments Acquisition Corp. Draft Registration Statement on Form S -1 Submitted March 13, 2015 CIK No. 0001635282

Dear Mr. Bonchristiano :

We have reviewed your draft registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing the information you provide in response to these comments and your amended draft registration statement or filed registration statement, we may have additional comments.

General

1. Please provide us with copies of any graphics, maps, photographs, and related captions or other artwork including logos that you intend to use in the prospectus. Such graphics and pictorial representations should not be included in any preliminary prospectus distributed to prospective investors prior to our review.

2. Please supplementally provide us with copies of all written communications, as de fined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, present to potential investors in reliance on Section 5(d) of the Securities Act, whether or not they retain copies of the communications. Similarly, please supplementally provide us with any research reports about you that are published or distributed in reliance upon Section 2(a)(3) of the Securities Act of 1933 added by

Antonio Bonchristiano GP Investments Acquisition Corp. April 9, 2015 Page 2

Section 105(a) of the Jumpstart Our Business Startups Act by any broker or dealer that is participating or will participate in your offering.

Cover of Prospectus

3. We note your disclosure on the cover stating that you “ will apply to list our units on the NASDAQ Capital Marke t, or NASDAQ, under the symbol ‘ GPIAU ’ on or promptly after the date of this prospectus. ” However, on page 105 under “Listing of Securities” you state that you “ have been approved to have our units, ordinary shares and warrants list ed on NASDAQ under the symbols ‘GPIAU,’ ‘GPIA’ and ‘GPIAW,’ respectively .” Furthermore, on page 116 under “Underwriting” you state that you “ have been approved to have our units listed on NASDAQ under the symbol ‘GPIAU,’ and that you “ expect that our ordinary shares and warrants will be listed under the symbols ‘GPIA ’ and ‘GPIAW,’ respectively, once separate trading for our ordinary shares and warrants begins. ” Please revise to reconcile these statements or advise.

Summary , page 1

General, page 1

4. We note that the summary includes performance and valuation information for GP Investments, Ltd . For example, we note your discussion of the potential sales value and realized return. Please remove from the summary section the performance and valuation for companies other than the issuer. This information is not appropriate for the prospectus summary.

Founder Shares, page 9

5. We note that your initial shareholders have agreed to certain voting provisions . Please revise your disclosure to indicate whether these provisions were provided in written agreements, and if so, please file such agreements as exhibits to this registration statement or advise.

6. We note that your initial shareholders have entered into letter agreements with you, pursuant to which they have waived certain redemption and distribution rights. Please advise us whether these agreements are the same as the insider letters containing transfer restrictions described under “Underwriting” and in cluded in the exhibit index. If not, please file such agreements as exhibits to this registration statement or advise.

Antonio Bonchristiano GP Investments Acquisition Corp. April 9, 2015 Page 3

Management’s Discussion and Analysis of Financial Condition and Results of Operations , page

Liquidity and Capital Resources, page 58

7. Please include disclosure regarding any expenses you have incurred to date.

Overview, page 61

8. We note your disclosure regarding your sponsor’s prior experience and the specific performance and valuation inform ation that you have provided. P lease ex pand the disclosure to provide a more complete discussion of performance. For example, please explain the basis for your realized return calculation. Please also explain what you mean by “potential sales value” and discuss how that figure is calculated. In addition, p lease balance this disclosure with a discussion of any relevant major adverse business developments. Please also revise to describe whether the return amount may have been impacted by general market trends or other external factors unrelated to management action. Further, please disclose any prior performance information for any other SPACs with which your control persons previously were or are concurrently associated or advise .

Management, page 79

9. We note that Mr. Lambranho will serve on your board of directors. Please revise to explicitly discuss the specific experience, qualifications, attributes or skills that led to the conclusion that Mr. Lambranho should serve as a director, in light of your business and structure . Please refer to Item 401(e) of Regulation S -K for guidance .

Number and Terms of Office of Officers and Directors , page 79

10. Please revise your disclosure to clarify the total number of directors you intend to have.

Underwriting, page 115

11. Please revise to disclose any historical banking and commercial dealings between the underwriter(s) and the company or its affiliates, or confirm that there have been no such dealings.

Exhibit Index

12. Please file all required exhibits as promptly as possible. If you are not in a position to file your legal opinions with the next amendment, please provide draft copies for us to review. Note that the drafts should be filed as correspondence.

Antonio Bonchristiano GP Investments Acquisition Corp. April 9, 2015 Page 4

13. We note the exhibit list includes “form of” agreements. Please advise us if you do not intend to file final, executed agreements prior to effectiveness of the registration statement.

You may contact Isaac Esquiv el at (202) 551 -3395 or Jennifer Monick at (202) 551 -3295 if you have questions regarding comments on the financial statements and related matters. Please contact Sara von Althann at (202) 551 -3207 or me at (202) 551 -3391 with any other questions.

Sincerely,
/s/ Erin E. Martin

Show Raw Text
April 9, 2015

Via E -mail
Antonio Bonchristiano
Chief Executive Officer
GP Investments Acquisition Corp.
150 E. 52nd Street, Suite 5003
New York, NY 10022

Re: GP Investments Acquisition Corp.
Draft Registration Statement on Form S -1
Submitted March 13, 2015
  CIK No. 0001635282

Dear Mr. Bonchristiano :

We have reviewed your draft registration statement  and have the following comments.  In
some of our comments, we may ask you  to provide us with information so we may better
understand your disclosure.

Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or  publicly  filing your registration statement on
EDGAR.  If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.

After reviewing the information you provide in response to these  comments  and your
amended draft registration statement or filed registration statement,  we may have  additional
comments.

General

1. Please provide us with copies of any graphics, maps, photographs, and related captions or
other artwork including logos that you intend to use in the prospectus. Such graphics and
pictorial representations should not be included in any preliminary prospectus distributed
to prospective investors prior to our review.

2. Please supplementally provide us with copies of all written communications, as de fined
in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your
behalf, present to potential investors in reliance on Section 5(d) of the Securities Act,
whether or not they retain copies of the communications. Similarly, please
supplementally provide us with any research reports about you that are published or
distributed in reliance upon Section 2(a)(3) of the Securities Act of 1933 added by

Antonio Bonchristiano
GP Investments Acquisition Corp.
April 9, 2015
Page 2

 Section 105(a) of the Jumpstart Our Business Startups Act by any broker or dealer that is
participating or will participate in your offering.

Cover of Prospectus

3. We note your disclosure on the cover stating that you “ will apply to list our units on the
NASDAQ Capital Marke t, or NASDAQ, under the symbol ‘ GPIAU ’ on or promptly after
the date  of this prospectus. ”  However, on page 105 under “Listing of Securities” you
state that you “ have been approved to have our units, ordinary shares and warrants list ed
on NASDAQ under the symbols ‘GPIAU,’  ‘GPIA’  and ‘GPIAW,’  respectively .”
Furthermore, on  page 116 under “Underwriting” you state that you “ have been approved
to have our units listed on  NASDAQ under the symbol ‘GPIAU,’ and that you “ expect
that our ordinary shares and warrants will be listed under the symbols ‘GPIA ’ and
‘GPIAW,’  respectively, once separate trading for our ordinary shares and warrants
begins. ”  Please revise to reconcile these statements or advise.

Summary , page 1

General, page 1

4. We note that the summary includes performance and valuation information for GP
Investments, Ltd .  For example, we note your discussion of the potential sales value and
realized return.  Please remove from the summary section the performance and valuation
for companies other than the issuer.  This information is not appropriate for the
prospectus summary.

Founder Shares, page 9

5. We note that  your initial shareholders  have agreed to certain voting provisions .  Please
revise your disclosure to indicate whether these provisions were provided in written
agreements, and if so, please file such agreements as exhibits to this registration
statement or advise.

6. We note that your initial shareholders have entered into letter agreements with you,
pursuant to which they have waived certain redemption and distribution rights.  Please
advise us whether these agreements are the same as the insider letters containing transfer
restrictions described under “Underwriting” and in cluded in the exhibit index.  If not,
please file such agreements as exhibits to this registration statement  or advise.

Antonio Bonchristiano
GP Investments Acquisition Corp.
April 9, 2015
Page 3

 Management’s Discussion and Analysis of Financial Condition and Results of Operations , page
57

Liquidity and Capital Resources, page  58

7. Please include disclosure regarding any expenses you have incurred to date.

Overview, page 61

8. We note your disclosure  regarding your sponsor’s prior experience and the specific
performance  and valuation  inform ation that you have provided.  P lease ex pand the
disclosure to provide a more complete  discussion of performance.  For example, please
explain the basis for your realized return calculation.  Please also explain what you mean
by “potential sales value” and discuss how that figure is calculated.  In addition, p lease
balance this disclosure with a discussion of any relevant major adverse business
developments.   Please also revise to describe whether the return amount may have been
impacted by general market trends or other external factors unrelated to management
action.  Further, please disclose any prior performance information for any other SPACs
with which your control persons previously were or are concurrently associated or advise .

Management, page 79

9. We note that Mr. Lambranho will serve on your board of directors.  Please revise to
explicitly discuss the specific experience, qualifications, attributes or skills that led to the
conclusion that Mr. Lambranho should serve as a director, in light of your  business and
structure .  Please refer to Item 401(e) of Regulation S -K for guidance .

Number and Terms of Office of Officers and Directors , page 79

10. Please  revise your disclosure to clarify the total number of directors you intend to have.

Underwriting, page 115

11. Please revise to disclose any historical banking and commercial dealings between the
underwriter(s) and the company or its affiliates, or confirm that there have been no such
dealings.

Exhibit Index

12. Please file all required exhibits as promptly as possible. If you are not in a position to file
your legal opinions with the next amendment, please provide draft copies for us to
review.   Note that the  drafts should be filed as correspondence.

Antonio Bonchristiano
GP Investments Acquisition Corp.
April 9, 2015
Page 4

 13. We note the exhibit list includes “form of” agreements. Please advise us if you do not
intend to file  final, executed agreements prior to effectiveness of the registration
statement.

You may contact Isaac Esquiv el at (202) 551 -3395  or Jennifer Monick  at (202) 551 -3295
if you have questions regarding comments on the financial statements and related matters.
Please contact Sara von Althann  at (202) 551 -3207  or me at (202) 551 -3391  with any other
questions.

Sincerely,

 /s/ Erin E. Martin

Erin E. Martin
Senior Counsel

cc: Michael Mies
 Skadden, Arps, Slate, Meagher & Flom LLP